Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with <sup>131</sup>I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation

Alberto Signore(CTO Andrea Alesini), Antonella Sgura(Roma Tre University), Jessica Marinaccio(Roma Tre University), Francesco Berardinelli(Roma Tre University), Giovanna Gentile(Sapienza University of Rome), Chiara Lauri(Azienda Ospedaliera Sant'Andrea), Francesco Colombini(Ospedale Misericordia - Grosseto), Giuseppe Campagna(Sapienza University of Rome), Maurizio Simmaco(Sapienza University of Rome), A. Tofani, Anna Giovanetti(National Agency for New Technologies, Energy and Sustainable Economic Development), Marco de Vitis(Roma Tre University), M. Chianelli(Ospedale Regina Apostolorum), Marina Borro(Sapienza University of Rome)
Journal of Nuclear Medicine
February 3, 2022
Cited by 14


Related Papers